(1)
Evaluation of the Pharmacotherapeutic Follow-up Effectiveness in Patients With Dyslipidemia in the Secondary Health Care in the Brazilian Unified Health System (SUS). Braz. J. Pharm. Sci. 2022, 58. https://doi.org/10.1590/s2175-97902022e20400.